UA112974C2 - Нікотиновмісна композиція (варіанти) - Google Patents

Нікотиновмісна композиція (варіанти)

Info

Publication number
UA112974C2
UA112974C2 UAA201304861A UAA201304861A UA112974C2 UA 112974 C2 UA112974 C2 UA 112974C2 UA A201304861 A UAA201304861 A UA A201304861A UA A201304861 A UAA201304861 A UA A201304861A UA 112974 C2 UA112974 C2 UA 112974C2
Authority
UA
Ukraine
Prior art keywords
nicotine
options
dosage form
nicotine composition
polacrylexic
Prior art date
Application number
UAA201304861A
Other languages
English (en)
Inventor
Бхарат Правінчандра Мента
Райєн Дхірубхай Шах
Маной Кантілал Пател
Пармешвар Б. Банг
Original Assignee
Джеі. Бі. Кемікалс Енд Фармасьютікалс Лімітид
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Джеі. Бі. Кемікалс Енд Фармасьютікалс Лімітид filed Critical Джеі. Бі. Кемікалс Енд Фармасьютікалс Лімітид
Publication of UA112974C2 publication Critical patent/UA112974C2/uk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Addiction (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Розкрито нікотиновмісну тверду пероральну трансмукозальну лікарську форму, що містить терапевтично ефективну кількість нікотину полакрилексу, моногідрат лимонної кислоти, сахарозу та рідку глюкозу, де вміст цукрового сиропу перевищує 95 мас. %. Лікарська форма більш прийнятно перебуває у формі пастилки.
UAA201304861A 2010-09-16 2010-01-12 Нікотиновмісна композиція (варіанти) UA112974C2 (uk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN2564MU2010 2010-09-16
PCT/IN2010/000775 WO2012035541A1 (en) 2010-09-16 2010-12-01 Nicotine containing formulation

Publications (1)

Publication Number Publication Date
UA112974C2 true UA112974C2 (uk) 2016-11-25

Family

ID=45831078

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201304861A UA112974C2 (uk) 2010-09-16 2010-01-12 Нікотиновмісна композиція (варіанти)

Country Status (10)

Country Link
US (1) US9180124B2 (uk)
EP (1) EP2496083A4 (uk)
AU (1) AU2010360967B2 (uk)
BR (1) BR112012031102B8 (uk)
CA (1) CA2782734C (uk)
EA (1) EA025779B1 (uk)
MX (1) MX339470B (uk)
UA (1) UA112974C2 (uk)
WO (1) WO2012035541A1 (uk)
ZA (1) ZA201206589B (uk)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9474303B2 (en) 2011-09-22 2016-10-25 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US9084439B2 (en) 2011-09-22 2015-07-21 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US9629392B2 (en) 2011-09-22 2017-04-25 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US20130078307A1 (en) 2011-09-22 2013-03-28 Niconovum Usa, Inc. Nicotine-containing pharmaceutical composition
US9763928B2 (en) 2012-02-10 2017-09-19 Niconovum Usa, Inc. Multi-layer nicotine-containing pharmaceutical composition
US9044035B2 (en) 2012-04-17 2015-06-02 R.J. Reynolds Tobacco Company Remelted ingestible products
ES2471665B1 (es) * 2012-12-21 2015-03-12 Farmalider Sa Producto sustitutivo del tabaco
EP3117826A4 (en) * 2014-03-11 2017-09-13 Farmalider, S.A. Tobacco substitute product
US11759419B2 (en) 2019-10-11 2023-09-19 Fertin Pharma A/S Compressed nicotine lozenge
CN111226941B (zh) * 2020-02-15 2021-08-20 浙江大学 一种防治作物害虫的植物源杀虫剂

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8317576D0 (en) 1983-06-29 1983-08-03 Shaw A S W Consumer tobacco products
GB8615676D0 (en) 1986-06-26 1986-07-30 Stoppers Co Ltd Nicotine containing lozenge
US5525351A (en) * 1989-11-07 1996-06-11 Dam; Anders Nicotine containing stimulant unit
US5110605A (en) 1990-08-21 1992-05-05 Oramed, Inc. Calcium polycarbophil-alginate controlled release composition and method
US5549906A (en) 1993-07-26 1996-08-27 Pharmacia Ab Nicotine lozenge and therapeutic method for smoking cessation
US5362496A (en) 1993-08-04 1994-11-08 Pharmetrix Corporation Method and therapeutic system for smoking cessation
TR199802305T2 (xx) 1996-05-13 2002-06-21 Norvartis Consumer Health S.A. Yanaktan uygulama y�ntemi.
NZ528167A (en) 2001-03-26 2005-04-29 Smithkline Beecham Corp Nicotine-containing oral dosage form
FR2823974B1 (fr) * 2001-04-25 2004-10-15 Pf Medicament Pastille medicamenteuse a liberation lente du principe actif
US20040107971A1 (en) * 2002-09-17 2004-06-10 Abhijit De Gum based chewing product and process for preparing the same
EP1578422B1 (en) * 2002-12-20 2007-04-11 NicoNovum AB A physically and chemically stable nicotine and micorcrystalline cellulose containing particulate material
DE102005058569B4 (de) 2005-12-08 2010-07-15 Lts Lohmann Therapie-Systeme Ag Schaumwafer mit Polyvinylalkohol-Polyethylenglycol-Pfropfcopolymer
ITTV20060039A1 (it) 2006-03-14 2007-09-15 Nice Spa Sistema di controllo per uno o piu' azionamenti.
US20090214442A1 (en) 2006-12-01 2009-08-27 Cephalon, Inc. Oral Transmucosal Nicotine Dosage Form
CL2009001025A1 (es) 2008-05-01 2010-09-24 Smithkline Beecham Corp Composicion de pastilla para chupar que comprende: a) un granulo patron con al menos: un agente tampon alcalino, un modificador de la disolucion y una carga, b) un principio activo de nicotina definido extragranular y al menos un agente tampon alcalino; procedimiento de preparacion; util para eliminar o reducir el uso de tabaco.
US20100124560A1 (en) 2008-11-14 2010-05-20 Mcneil Ab Multi portion intra-oral dosage form and use thereof

Also Published As

Publication number Publication date
EP2496083A1 (en) 2012-09-12
MX2012012973A (es) 2013-03-05
ZA201206589B (en) 2014-02-26
US20120244104A1 (en) 2012-09-27
US9180124B2 (en) 2015-11-10
BR112012031102A2 (pt) 2015-09-22
MX339470B (es) 2016-05-27
CA2782734A1 (en) 2012-03-22
WO2012035541A1 (en) 2012-03-22
AU2010360967A1 (en) 2012-07-05
BR112012031102B8 (pt) 2021-05-25
CA2782734C (en) 2018-03-27
EA201390394A1 (ru) 2013-07-30
EP2496083A4 (en) 2013-05-01
AU2010360967B2 (en) 2015-08-20
BR112012031102B1 (pt) 2021-05-18
EA025779B1 (ru) 2017-01-30

Similar Documents

Publication Publication Date Title
MX339470B (es) Formulacion que contiene nicotina.
WO2012092594A3 (en) Preparations for topical prevention and/or treatment of oral allergic symptoms due to oral contact with fruits and/or vegetables
WO2014207770A8 (en) A medicinal composition of amaranth extract origin having enriched nitrate content and a method of preparing the same
UA108360C2 (uk) Тверда фармацевтична композиція кортикостероїду, що розпадається у ротовій порожнині
DE602007007991D1 (de) Kleinvolumige, orale, transmukosale dosierungsformen mit sufentanil zur schmerzbehandlung
NZ623495A (en) Oral formulations of cytidine analogs and methods of use thereof
MX2010006284A (es) Formulaciones farmaceuticas de fenilefrina y composiciones para la absorcion transmucosal.
WO2007125545A3 (en) Transmucosal composition
WO2012079092A3 (en) Testosterone undecanoate compositions
WO2010039762A3 (en) Pharmaceutical compositions comprising boronic acid compounds
RU2013121576A (ru) Составы для лечения заболеваний верхних дыхательных путей
WO2007012019A3 (en) Medicaments containing famotidine and ibuprofen and administration of same
PE20080994A1 (es) Jarabes antihistaminicos, estables al almacenamiento sin azucar
MX2015008837A (es) Composiciones parenterales estables de dnj.
MY139913A (en) Chewable, suckable and swallowable tablet containing a calcium-containing compound as an active substance
RU2007107368A (ru) Композиция, содержащая десмопрессин
EA201170108A1 (ru) Сосательная композиция для лечения воспалительных заболеваний полости рта и глотки
TN2015000267A1 (en) Solid unit with high fexofenadine content and process for the preparation thereof
WO2008075320A3 (en) Antilipidemic pharmaceutical compositions and process for preparation thereof
MX346039B (es) Solucion farmaceutica bebible de telmisartan.
PT2252263E (pt) Forma galénica para a administração de triptanos por via transmucosa bucal
CN102342896A (zh) 一种生物酶漱口水
WO2011161223A3 (en) Pharmaceutical oral dosage forms comprising lercanidipine and enalapril and their pharmaceutically acceptable salts
WO2010135505A3 (en) Crystalline forms of 4-[6-(6-methanesulfonyl-2-methylpyridin-3-ylamino)-5-methoxy-pyrimidin-4-yloxy]-piperidine-1-carboxylic acid isopropyl ester
PH22011000655U1 (en) Pharmaceutical herbal composition